Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
ann
all you have to to is apply for membership on the other board and I know you would be accepted. As long as you have the same nic there as here that is other wise nappy will not know it is you. If it is different give me a private reply here and I will let him know what it is.
cowboyd
A Simple clarification
I want to be sure there is no doubt in anyone's mind I did not make any of my comments with the intent to encourage people to shift boards. Over time this forum has proved to be head and shoulders above any other source for the reasonable discussion of the company and I hope it continues to do so.
cowboyd
Ming
I tip my hat to you. You are immeasurably more tolerant than I am and this board is a much better place because of it. I hope your final analysis will allow you to remain even if you relinquish your moderator role. A WELL DONE does not do justice to your efforts here but it is the best this scenario allows.
cowboyd
Chris
It is an old tired one at best, me. That board is not a democracy by any means. I decided a long time ago that no personal attacks would be tolerated and instead of repeated efforts to reform an offender their membership is just revoked. I have no problem with negative perspectives as long as they have a reasonable and logical basis. No matter how skilled the author is with his or her attempts to skirt the lines of the boards intentions, a place for the sincere and honest exchange of ideas about DNAP, if I believe they don't belong they go.
It is important to realize this does not always promote an extensive amount of chatter but what is there tends to be on target. I will also tell you in its history only one member was removed and only five or six posts have been deleted.
In an age of unilateral access to almost everything I understand many people do not approve of or relish what they perceive to be a heavy handed atmosphere and I readily accept and respect their pov.
The real purpose of my comment was to caution those here that want to see the removal of certain posters that the road has some serious pitfalls along the way. I have the utmost respect for Ming, Dick and the others for the job they have done here and more than empathize with the burden a busy board like this places on them. I doubt if the majority of posters here really comprehends just how much work these folks have but into it.
I also think ignorant comments about anything that even implies this board would be better without Ming remove any doubt about the intentions or validity of those posters.
JMHO and worth what you paid for it.
cowboyd
Paul
Thank you for you continued efforts as well and thanks for the occasional post to the old board. I suspect at some point in the distant future it will once again have life breathed into it as this company grows and shows results measured in revenues and not potential.
JMHO and worth what you paid for it
cowboyd
Robert
As always thank you for your continued efforts. I hope the board here realizes the tremendous asset they have in you. I do appreciate the composite list. I suspect your know I do not have the time to follow each and every one of these developments and it is a real positive reinforcement to see the numbers. I doubt if all will come to fruition but with the bottom line numbers for even one product they do not have to. I have long maintained the true value of Admixmap will be the ability to resurrect the billions of dollars thrown away at failures of drugs which have reached the second and the third stages of FDA testing. New life granted for and development fee for the test and a royalty fee on sales would make the investors similar to the Yahoo millionaires of old. The previous thought when paired with the pending acquisition just continues to add to the block buster potential I see.
I do think that the number of outstanding shares remains a logistics problem and fully expect some consolidation in the future but with many if not most of the investors owning hundreds of thousands of share that should not be a major concern.
JMHO and worth what you paid for it
cowboyd
Greetings old friends and new.
I have just spent some time catching up over here and what I find is most interesting is that month in and month out all these boards are faced with the same basic synergy. The majority of time is spent between obvious basher types and the opposing pro contingency trying to refute these seemingly meaningless attacks.
IMHO the individual risk tolerance of each investor dictates wether or they should be here. That said anyone who does not understand investment in pennies is nothing more than a slightly educated crap shoot has missed one of the very basics of this market place.
With all that said I continue to believe this little company has more going for it on the potential side than any other I am aware of. The basic's have not changed even with the pending acquisition because we are left, in essence, with only potential and no substantive results that can, on their own merit, support the financial needs of our company. This will not change until we have a repeatable and sustainable revenue stream.
The single biggest obstacle is not the validation of the science it is the ability to get it used and accepted. That seems to be being worked on as well as I can expect. The amount of time it is taking is most frustrating but if, and that still remains a big IF, it can be accomplished the remaining investors will be rewarded handsomely.
I would encourage you to perhaps pay less attention to the naysayers and more to the efforts of this little company. I see light at the end of a very long tunnel but the train is moving very slowly.
Keep the faith if you have the time and don't let others irritate you. The private board on DNAP still exists but it is virtually dead. The price we pay for very restricted membership is a loud silence during these developing times. Before you ask and receive for removals of trouble makers here think about what the long range consequences may be of only positive points being raised.
Enjoy yourselves and live life, if ignored and not engaged the evil empire will soon bore itself to death.
JMHO and worth what you paid for it
cowboyd
Hello all just checking in to see who is still around and what if anything is happening. I am glad to see most of the faithful still here as the stock seems to be floating along waiting for something substantial to break. Looking at volume and price am I safe to assume nothing outside day to day operation and progress is expected in the next 3 to 6 months?
Take Care and Be Well
cowboyd
hello all
It has been an interesting few days here with the news from the meeting or lack of it more correctly. I really do not see much to worry about we are still the same company we were a year ago at this time, imho. We have made some progress and seem to be focused on eventual success but in fact all we really have is potential and some minor revenue to sustain us for,I believe someone said another 20 months at the current burn rate.
Potential is just that and until the company can release some substantial news to indicate sustainable profits we will remain as a company with potential. Now don't take this as a negative it is just a realistic evaluation of where we are. The risk reward scenario is what these pennies are all about and in that light, again imho, you would be hard pressed to find another with this much national attention and exposure. We are involved in an industry that has not only huge potential but also is the one at the focal point of the investment community's interest.
The bottom line, for me, is that each investor has to do a serious and periodic review of his or her investment risk tolerance. To play in the pennies it has to be high and money put here really has to be disposable. Those of us who are here, I don't distinguish between how long you have been here, are doing a combination of rolling the dice and making and intelligent active decision that the potential for DNAP out weighs the risk of its failure.
I am still here and have no immediate plans to make any significant changes in my position in either direction. I like what I see and the progress that appears to be made by the company. I wish you all good luck in your investments and although I am not nearly as active as I have been in the past years, as far as DNAP, I do check the boards several times a week. I also want to thank those of you who still visit and contribute to the long board at RB as time allows.
JMHO and worth what you paid for it
cowboyd
Hello all
I just stopped by for what now I call periodic visits. I see little has changed except the level of the banter between pro and con is perhaps a bit more literate. The company imho remains status quo. That is showing immense potential but yet to prove itself in the fields that will reward investor patience in the most favorable way. Forensics is nothing more than an income stream to fund research and can never substantial affect a company with this many outstanding shares.
I was asked on the other board my views on Dutton and they are simply that at this point any coverage by any type of reliable source, funded or not, is good. The basic truth remains shareholder value can not increase with out a substantial increase in the base size of the investors. Current investors and the faithful are either tapped out or have reached the level of prudent risk tolerance and beyond. New investors are needed and they can not come without exposure. Hence bottom Dutton is good.
Good luck to us all and hi to W2P, Ming, Cosmic etc.
BTW should news break someone please remember to stop by the private board on Lycos it is still there and as dead as ever lol
The above are my personal opinions and worth exactly what you paid for them.
cowboyd
Just stopped by to say hello
It has been a while since I have posted and just wanted to stop by and say a quick hi. I see by the number of posts that many have come to the same conclusion that I have. Simply put the company still has loads of potential and as long as the capital exists to carry them through sooner or later that potential will develop into productive products and earnings.
I don't want to belittle the forensics applications but I have always maintained they are merely an avenue for revenue to help this company get into the real money stream of personalized medicine. This journey is slower but not longer than I anticipated but my opinion remains positive for the eventual success of this company.
Be well and good investing
cowboyd
Well finally something to get excited about!!!!!!!!!
Much more than the alliance has happened here our technology has in effect be validated for its potential value from a leading organization in its field. It would not surprise me in the least to see more similar announcements made down the road.
TODAYS SCORE FAITHFUL 1 BASHERS 0
JMHO and worth what you paid for it
cowboyd
OT Thanks All buried in work, thankfully not snow, and didn't even think about the rate announcement. IMHO markets will be very interesting, investors really want to believe the upturn is for real but several years of bad news has made most still shell shocked and very sensitive.
The brightest aspect of this whole recovery is that I think tech in the form of Bio will lead us out and into the future. I don't think we will see the craziness of the Dot Com age but there will still be a lot of great stories to tell. I hope DNAP is one of them.
JMHO and worth what you paid for it.
cowboyd
OT anybody know what news kicked off this sell off?
THG
glad to see you still alive and I hope well.
cowboyd
Welcome
I would like to extend a warm welcome to all who stuck with the company over the years either through choice or just because they got caught by the lies of the past management.
I also want to welcome those new investors who are just discovering this company. I am sure in a short while you will have a group of long time investors who can give you background of the many lives of this company. Above all remember it is a BB with high risk and higher if you give any credence to its tainted history.
JMHO and worth what you paid for it
cowboyd
Some interesting discussion in an otherwise slow time.
One aspect that I have not seen discussed regarding the value of the forensic's test is the fact that this is only their initial product and as we remember it only a bye product or their original thrust. One cop's opinion on the relative cost to value is far from a majority point of view. While it may be true that in its current stage the forensic's test is only sketchy I suspect in a very short time frame additional refinements already developed will be added. Each new generation will not only add value but with significant improvements may well justify higher prices.
Before some become too jaded it was not that long ago all that could be done with DNA was to match it to an existing sample. DNAP is just beginning to mine the secrets it holds.
BTW anyone here trying to compare the potential of DNAP to GMED, over the long term has not got a clue. That is not saying anything negative about GMED more so a lot positive about DNAP.
MHO and worth what you paid for it.
cowboyd
The dog days have come early this year LOL EOM
Dick
Remember I clearly stated it was speculation on my part but be sure to read ann's post
http://www.investorshub.com/boards/read_msg.asp?message_id=2131440
It really gives a great background for my speculation.
The answer to the other revenue streams is there has not been much released on them so I can only assume ( knowing full well how dangerous that is ) that they are still underway. If I remember correctly they were specific tests for specific maladies and treatment regiments. I am sure that process is a long one but that exact service is what I am suggesting would be available to the pharms in general on a fee based arrangement. Double edged sword income for the process and income for each test as it is performed wether in house or through a license arrangement.
Stop and think of the value this kind of testing would have for a rejected or removed drug because the FDA considered the risk factor too high. If they could offer a test that would predict within 98 or 99% accuracy an individual would not experience the adverse affects that drug could be again sold as long as the test was administered.
The only other factor in this whole FDA scenario is the infamous political one. The question being not only does DNAP have the best technology but do they have enough political impact to be acknowledged.
BTW I don't think I have ever said this was going to make us rich I do think with the level of risk taken into account it does offer a reasonable chance for exceptional returns if the company can make it on the funding it has secured.
JMHO and worth what you paid for it.
cowboyd
OT Ann thanks very timely. If I ever need a research staff you would be my choice for director.
cowboyd
OTOT bag for what it's worth you WIN! LOL
Dick
I am having a slow day so I can play a little. The following is PURE SPECULATION AND NOT BASED ON ANY FACTS JUST THEORIES.
The only products that I think the company has in works that have the potential for any kind of serious revenue must be in the personalized medical sector. That sector would most likely include genetic analysis for drug compatIbility for specific maladies. I would love to believe that the stated dream of drug acquIsitions for proprietary distribution is a real possibility but to date I have seen nothing to support it.
The forensics and recreational application of their technology would seem, at best, to provide a revenue stream to cover current and near future operational and partial research efforts. This aspect of their revenue stream will not likely lead to the so called " home run" the investors are hoping for.
If I were forced to throw at the proverbial dartboard for success I would say the most exciting potential aspect for the company, as I see it today, would be for them to be certified as an approved resource by the FDA for the necessary validation of current and developing drugs for the safety and effectiveness in their specified applications.
JMHO AND WORTH WHAT YOU PAID FOR IT
cowboyd
OT bag LOL
In that example I would concede but if your responding to my example those same " yahoos " would have had to campaign for a year and the question would be what on earth did you do to them to incur that kind of wrath.
cowboyd
Bag first thanks for a most gracious compliment.
I like the rest of the investors am here because I believe the " POTENTIAL " for the future value of this company far exceeds today's real evaluation. Unfortunately we can not choose the standard for real valuation based on how it suits our needs. If the future share price will reflect the company's value then logic dictates the current must also.
Value can only be defined by the marketplace. Much like a home owner who feels his house is worth $500,000 but the best offer he can get after a year of marketing is $400,000. That lower price is exactly what the real value of the property is as defined by the marketplace. Now the owner can choose to not sell at that level but there is little room to argue that the value is greater because no one is willing to pay for it.
At this stage I think we may be parsing words because by the spirit of your statement " But when it comes to DNAP's value today, I'll take Dr Frudakis's perceived value over that heaped upon us by share price " I think you are really saying the same thing regarding potential vs current value.
The challenge, after the current funding was secured, is really how is the company going to generate revenue numbers to support an acceptable capitalization ratio to justify the necessary share price for acceptance on a major exchange. I don't know for sure but I think the NAZ small cap is either $3 or $4 dollars. If we make a supposition that we will have issued 1B shares at a 10-1 ratio that would mean we will have to have $300,000,000 net profit to qualify. Obviously the actual listing requirement could effect that as well as a more generous ratio but I know you can see where this is leading.
The only other way to reach that capitalization level is by reduced share levels. The much talked about RS is always an option but so too is a corporate buy back and reduction of the authorized shares to levels just above the issued ones.
This is all way down the road and long before that IMHO todays investors will have substantial returns on their investments based on today's levels. Let's face it those that bought in at the two cent level are today already looking at around a 300% return. The potential remains IMHO but so too does the length of the time frame.
Good luck and please keep up your efforts there are many of you who have contributed much to the level of discussion and information on this forum.
JMHO and worth what you paid for it
cowboyd
bag
I seldom find any real difference of opinion with you and even in this instance I would agree that your perception of value has some logical basis. However in the end there can really only be one practical yardstick for the measurement of value of any publicly traded company. That is it capitalization rate which is obviously dependent on it share price.
The issue of the amount of authorized and issued shares will always remain because of the capitalization factor as this will directly affect the company's ability to reach a share price to qualify for major exchange listings.
The above is not a condemnation of the financing choice for share issuance over long term debt or any aspect of it ( that is a no win discussion for both sides ) it is just meant to point out that no matter what the arbitrary value any side may want to ascribe to a thing the ultimate value will be defined by share price. That share price may in some way on a short term basis be affected by Pr's message board nonsense etc. but in the long term the true value will be based on financial statements and the earnings or lack of that are shown.
JMHO and worth what you paid for it.
cowboyd
Mjam
I doubt if there are any legal preventatives to prohibit DNAP from wearing both hats but I think there are many practical ones.
Let's role play for a second. You have developed a new drug with tremendous potential to address a wide spread malady and if approved will generate staggering financial rewards. At the same time you are working on this application several other competitors are working for the same goal. In the final analysis the first one to pass the FDA approvals will have a huge market advantage and maybe a technical one.
The FDA now mandates genetic verification for all applications in this area and it just so happens that the preferred or better stated most acceptable documentation for these approvals is being done by one of your competitor's testing divisions. How much confidence will you have in turning over all your development data to the competing company no matter how many assurances that the testing division has no contact with the development division. At best this is extremely uncomfortable and I think the FDA might in fact recognize the potential for conflict and specify that verification organizations can not be part of development companies even if they are separate division.
All the above JMHO and worth what you paid for it.
cowboyd
Mike
There is really no need to alter the drug. Many of the rejections at this late stage are based on the percentage of people who will experience the negative side affects and the severity of them.
One of the most interesting aspects of this type of testing is that it would allow countless number of highly beneficial drugs which have either been rejected or pulled after all the intense dollars have been spent to reach this stage of development. One logical scenario would be for the FDA to approve the use of these drugs on the contingency that all users first are tested to insure they will not be subject to the negative side affects. The FDA must first recognize the validity of such a test but I suspect the costs associated with this process would be minuscule in comparison to the monies already thrown out the window by the drugs rejection. IMHO win win for everyone.
The only aspect of this type of testing scenario is that I think it would be highly unlikely that other Pharms would want a competing drug company involved. I for one would rather see the company as part of the FDA standard for testing and profiting from a steady stream of verifications than waiting for its own home run in a drug development scenario.
cowboyd
Another very interesting day for DNAP. I want to point out a factor that I have not seen mentioned. While it looks like we will hit the 22M volume mark today the price range certainly indicates the effects of the traders. ( 0.065 - 0.085 as of 2:30 pm ) but what it does not account for is the significance of this level of volume on a very slow market day and week from a volume stand point. You can pick what ever factor you want but I believe that had this attention happened during a normal trading period we could have seen the volume another 30 to 60% higher.
The other significant issue already mentioned elsewhere but I want to highlight it as well is that all this publicity is media driven by external forces and does not at all reflect any type of the so called " typical penny stock pumping pr " strategy that many elsewhere seem so intent on finding.
Again hope all here had a joyous holiday season and I hope the New Year brings many wonderful blessings to you and your families.
JMHO and worth what you paid for it
cowboyd
MERRY CHRISTMAS AND A HAPPY NEW YEAR TO ALL OF YOU
cowboyd
2 cents on last 24 hours
There has been so much deliberation on this announcement on the other boards that I doubt if anything I have to say will shed any new light but since I always liked the expression " In for a penny in for a pound " I will wax on.
There are several major issues facing DNAP, as well as any young unproven company. The first issue is what do they have to offer that someone is willing to buy? Secondly how are they prepared to merchandise or advertise this product so their potential market place can have the opportunity to buy it? Thirdly, and lastly for this discussion, do they have enough financial backing to last long enough to implement the distribution of their products?
The first issue is ever unfolding for DNAP and as I have said in the past their forensics and recreational products certainly do not seem to offer enough potential from a fiscal return ratio to garner anywhere near the interest that has been associated with this company. The real money can only be made in the applied medical application sector or what we have become accustomed to referring to personalized medicine. That area will take a lot longer than many of the investor cast of characters is willing to recognize. It will also take much more financing than the company has been able to show until now. It has become apparent that the initial products in the forensic's field and recreational area may have the potential to sustain their minimal operational expenses but will fall far short of the necessary funding for the clinical phases of the medical product's development. IMHO the MOST important aspect of this funding arrangement is that it WILL ALLOW THE CLINICAL PHASE TO BEGIN. The completion of this step will allow for submission for the eventual FDA approvals necessary to bring these products to market.
Secondly as Mr Gabriel said in the PR they now have the funding to expand their work force to allow for a real sale's staff. I expect the initial thrust will have to be for existing products in both the forensic's and recreational areas but this time should also be used to begin the development on in roads for the medical applications when they are approved for market. This last aspect of the need for approval from the FDA is arguable but I believe any serious review of the situation will cause the logical reviewer to conclude that while the letter of the law may be gray, NOW, for its need. There is little doubt that the future will demand it.
Lastly this funding allows the company to concentrate on the development and merchandising of product instead of focusing on how to pay monthly bills. Investors can second guess all they want about the wisdom of management's previous alternatives for funding but remember we are all doing this with the great benefit of "HINDSIGHT" and tend to be too harsh on the initial management's initial choices. Bottom line is they have kept us afloat to be in a position for this next stage of development. I also think it was an extremely important aspect of development when the management was reorganized to acknowledge this lack of business acumen and bring people on board who appeared then to be qualified and now have shown investors the first tangible signs that they have begun to produce results.
The company still has a long long way to go before it has any chance of taking anyone " TO THE MOON " and some old issues still remain to trouble investors such as the Float Size, will we be the first or best to market etc.. ( by the way for the math crew at $4 a share what kind of capitalization value with this company have to have in order for DNAP to qualify for the minimum criterea for the Naz small cap listing? Please remember that valuation has to be based on real revenue ratios to share price )
In the final analysis what this funding means is that management has secured the opportunity for continued development of main line products and the continued operation of the company for the next twenty months. I would say that puts DNAP in a substantially better postition for potential success than it was before the arrangement. The associated negatives for dilution or minipulation are merely a fact of life for emerging companies in this or any sector and investors who can't accept that don't belong playing in these waters.
The above as always is JMHO and worth what you paid for it.
cowboyd
Happy Thanksgiving to you all!
Let's all take some time to share our bounty with those less fortunate as a tangible way of showing our gratitude for the blessings of our families,and friends. It seems life teaches us with those two forces backing us the material things have a way of taking care of themselves as life experience puts each into proper perspective.
IMHO worth more than you paid for it
cowboyd
Doug
One the most interesting aspects of that release from DNAP's POV might be the following.
" The American Heart Association meeting is being held during the same week that the Federal Drug Administration (FDA) is holding a workshop (on November 13th), entitled "Pharmacogenomics in Drug Development and Regulatory Decision-Making: The Genomic Data Submission Proposal," to discuss guidelines for submission of Pharmacogenetic data to the FDA, including DNA-based diagnostic tests for use with drug therapy."
Does anyone here know if the company has any more input than we knew about in earlier months. It could be very significant for DNAP to have any influence on the imprint of the standards for those submissions.
JMHO and worth what you paid for it
cowboyd
Ming
There are several interesting aspects of your find. First while I would like to believe that the mention of DNAP in an article along with the CIA and other governmental agencies would infer an association or at least familiarity by those agencies I don't find myself able to do so.
I don't doubt there is a great possibility that this awareness exists but the article by itself offers not real proof of it. The fact that I do find much more interesting is not only the quote by Tony that we can infer because of his awareness of this pending tech that he may well have more that just a casual knowledge of the technology but also the author TABASSUM ZAKARIA is aware enough of DNAP to seek or obtain that quote.
If you do a quick search on TABASSUM ZAKARIA you will see the vast majority of articles written by him, that pop up in a simple Google search, deal with the mechanisms of conflicts or military aspects trending toward the intelligence side. While there is a chance he may have become aware of DNAP though some of the forensics press I find it very likely that he may have stumbled on to them while researching other articles or through some of his intelligence type sources.
The main point here is that this may be the tip of a smoking gun indicating little DNAP has another very serious aspect to its potential. Not that forensics, personal medicine, recreational genetic applications ( including cosmetics ) don't offer enough potential but this may well be an clue to that mother load of all funding and revenue the " DOD ".
The above is just pure speculation based on this mention in the Economic Times as well as other past implied associations but none the less still interesting.
What are your thoughts?
JMHO and worth what you paid for it.
cowboyd.
I am surprised how quiet it is here today so I'll repost a Nap Heads post to fill some space.
While I don't think yesterday's news was considered a major development it was certainly noteworthy! I have long considered the forensic end of the business as only the most immediate form for needed revenue and a good way to get the company's name in front of potential investors.
I continue to think the real money will come from the medical front but have come to accept that time line seems further and further out especially in light of the change in emphasis towards drug development as opposed to genetic qualifiers for existing drugs.
It is always a concern for young companies, like this one, seeking an identity that in that search they spread themselves too thin on multiple fronts instead of concentrating on only one or two.
IMHO the foremost challenge for DNAP continues to be establishing a RELIABLE source for funding the day to day operating and research costs without the need for continued PP and share issuance. The next quarterly report should show the beginning of a limited sustainable revenue stream from the forensics division, assuming that we did not give away all that work for the exposure. ( in itself that might not have been all bad with the significant need to establish the value of the witness product but the company's need for revenues must be addressed )
I want to be sure that any of the spin doctors don't try to take the above as any kind of wavering in my optimism for the potential of this company because that is not the case. I still believe in the context of the risk of all emerging companies traded on the BB or Pink markets this company still has all the signs for great potential returns for the investors who have risked their capital here.
I do understand the value of the IHUB board and the discussions there in but I would also like to encourage those of you who belong to both to share some of those thoughts here as well in the serene forest Nap Head Land.
Of course JMHO and worth what you paid for it.
cowboyd
Bign
First of all if anyone could factually answer that they would not be wasting time on a message board. It concerns me you might actually take advice from a message board, even one as good as this one. You and only you can make the right decision about when to sell or hold based on your individual risk tolerances and financial circumstances. Preaching aside I know of no way to base a realistic answer because all we have with DNAP is POTENTIAL and a little media recognition for some forensic success.
I used to think there was a great deal of potential in the personalized medicine area based on the list of presentations made by Dr. T. and the DNAP team at high quality industry events and conventions. Those presentations seem to have dried up and have been replaced by more forensic type ones. I don't know what that means. Perhaps the academic or better said scientific community has internally refuted those presentations or perhaps the company has such a lead they no longer feel the need to vindicate their technology, it is your choice.
I have never looked at this stock from a short term perspective and continue to feel its potential will only be reached in a time frame measured in years as opposed to months. Like all BB's or Pinks its single biggest issue IMHO is can it secure solid funding to carry it over until it has products that are sufficient enough to insure its existence? Even when that self sustaining revenue level is reached it will have to face a whopper of a float before it has a chance to make a major exchange and the added security trading there offers.
I doubt very much if this is what your are looking for but they are my thoughts on the subject. I do tend to get preachy in these things but don't mean to offend or insult your intelligence in any way.
The above is JMHO and worth what you paid for it.
cowboyd
early
That was a very interesting reference for the company to a very distinguished audience. For those of you in a time crunch the following are the profiles of the two presenters for that segment and the text referring to DNAP.
I wish we had been referenced in regards to personalized medicine as opposed to recreational use and the brief forensic's note but any press is good press IMHO.
Eric S. Lander, Ph.D.
Director
Whitehead Institute/MIT Center for Genome Research
Professor of Biology
Massachusetts Institute of Technology
320 Charles Street
Cambridge, MA 02141-2023
Ethical, Legal, and Social Implications of Genetic Technologies
Eric T. Juengst, Ph.D.
Associate Professor of Biomedical Ethics, Case Western Reserve
University School of Medicine
" So what's the message we want to give the public about that? Ego genomics Part III, if you will. The
world's first recreational genetic testing service is how they bill themselves, DNAPrint Genomics, a
company in Florida that says it will measure your racial ancestry and racial proportions for you using
DNA markers. Well, why would you want to do that? Perhaps for genealogy or to validate your
eligibility for race-based college admissions or government entitlements. Here's some of their literature
from their website. "Have you ever wondered if you're of purely Indo-European origin, or a blend of
Indo-European or Native American or other ancestry? We can answer that. Capable of determining your
precise ancestral proportions might reveal you're 80 percent African," et cetera, et cetera.
Who is interested in this test? Well, genealogists, the adopted. One customer used the test to hone his
search for an organ donor. Another suspected he was of significant Native American heritage but had no
way to prove it. The test gave him a sound basis by which to claim access to commercial opportunities
reserved for Native Americans. "So whether you're just curious or your goal is to achieve social status of
a particular group, we can help you do this."
Well, again, junk science? I personally don't know. There seems to be a lot of contention within the
genetics community about whether this is realistic and meaningful or not. But it certainly feeds into our
race consciousness in this culture, and you can see ways in which people's motivations for acquiring this
test for themselves, for their children, for their potential spouses, would only go in the wrong direction.
In fact, this is, again, luxury genomics that is a recreational service, but it has already been put to at least
one serious use. They've used the DNAPrint testing procedures on a forensic sample to reorient a search
for a suspect from one race to another.
So here we are. Here's my summary of the issues that I would like to put on your agenda. First is to
continue our exploration of this calculus of the eight P's about how we validate genetic tests. Second is
to continue the pursuit of good genetic protections, good protections against genetic discrimination.
Third is to continue the discussion of the regulation of commercial genetic testing with an eye towards
the direct-to-consumer uses."
Food for thought and comments as to impact this exposure may have for or against the company?
cowboyd
grateful's post 7429 is the only link I can get to come up and the infamous " http://www.dnaphenomics.com/images/DNAP50logo.gif " is still there. Rather than a slip in to some secret association with our DNAP I think it was just the easiest way to name the gif.
JMHO and worth what you paid for it on a quiet dull DNAP day LOL
cowboyd
early
I think conventional wisdom has agreed many if not most of Tony's sales would appear to be just part of a planned buy sell program to avoid keeping Martha company. Many insiders in many companies have adopted this type of strategy.
cowboyd
Interesting volume surge!
What are the running theories as to why? I see no news to justify this beyond the federal DNA criminal expenditure bill?
cowboyd
Hello all quite a day for premises and counter premises.
The kinds of stories that are floating around have the potential for too many innuendos to even start a semi-comprehensive list.
The thought that the so called " Brain Trust " has in part of all left the company is indeed disturbing on face value. This apparently valid reason for concern may prove to hold up under close scrutiny or it may be one whopping bowl of sour grapes.
If the company has truely made the decision to make a radical change in direction it could be very understandable that once key and essential staffers are now excess baggage. If that is indeed the case then their bitterness is not only understandable but worthy of empathy. However if this business decision is for the good and future benefit of the company's long term survival and eventual success that change may well be in the best interest of the investors.
The other side of the coin is that if the change was not so voluntary as mandated by an inability to meet the original business plan and market those products then this may be the last attempts of a badly floundering company to stay a float.
I for one do not have a clue because both scenarios are plausible and ONCE AGAIN THE INVESTORS find themselves in the position that time will be the final judge.
I think we are all in the position of giving time and the marketplace a chance to sort out this latest twist and each must decide if staying or leaving meets there individual investment needs at this potential crossroad.
My last observation is more of question, is it my imagination that there seems to be a track record of this type of turmoil just before a weekend when there is two or more days to agonize the investors and cause an early sell off Monday or is this just the fruits of my aging imagination?
As always JMHO and worth what you paid for it!
cowboyd